Tadalafil (Generic) Missed-Dose Protocol: What to Do When You Skip a Pill

At a glance
- Drug / tadalafil (generic for Cialis), PDE5 inhibitor
- Available doses / 2.5 mg, 5 mg, 10 mg, 20 mg oral tablets
- Daily regimen / 2.5 mg or 5 mg once per day, same time each day
- On-demand regimen / 10 mg or 20 mg taken 30-60 minutes before sexual activity
- Half-life / 17.5 hours (longest among approved PDE5 inhibitors)
- Time to steady state / approximately 5 days of consecutive daily dosing
- Missed daily dose rule / take same day if remembered; skip if next dose is near
- Never double dose / taking two tablets to compensate increases side-effect risk
- FDA-approved indications / erectile dysfunction (ED) and benign prostatic hyperplasia (BPH)
- On-demand max frequency / one dose per 24-hour period
Why Tadalafil's Half-Life Changes the Missed-Dose Calculus
Tadalafil behaves differently from sildenafil or vardenafil when a dose is missed because its terminal elimination half-life sits at 17.5 hours, roughly three to four times longer than the other two drugs. That pharmacokinetic property means plasma concentrations decline more slowly after a skipped tablet, giving patients a measurable buffer that shorter-acting PDE5 inhibitors cannot offer.
Forgue et al. characterized tadalafil's single-dose pharmacokinetics in healthy volunteers and reported a mean Tmax of 2 hours, with measurable plasma drug levels persisting beyond 24 hours after a 20 mg dose [1]. The clinical significance is straightforward: missing one daily 5 mg tablet does not zero out your blood levels the way missing a 4-hour half-life drug would. Residual tadalafil remains in circulation, though concentrations will fall below the steady-state trough that continuous daily dosing maintains.
Brock et al. demonstrated in their 2002 trial that tadalafil's extended duration of action, up to 36 hours in the on-demand setting, distinguished it from sildenafil and established the pharmacological foundation for daily low-dose regimens that followed [2]. That long window is precisely why the missed-dose protocol for tadalafil is more forgiving than for most oral medications.
Still, "more forgiving" is not a license to skip doses casually. The steady-state concentration achieved with daily 5 mg dosing (typically reached by day 5) depends on consistent intake [3]. Each missed dose delays or disrupts that plateau.
The Standard Missed-Dose Protocol for Daily Tadalafil
The FDA-approved labeling for tadalafil tablets states the rule plainly: if a dose is missed, take it as soon as you remember that same calendar day [3]. If you realize you forgot your morning tablet and it is already late evening with the next dose due in a few hours, skip it entirely. Resume your regular schedule the following day.
Do not take two tablets at once. Doubling the dose does not restore the steady state faster, and it raises the likelihood of side effects including headache, dyspepsia, back pain, and flushing. In registration trials for daily tadalafil 5 mg, headache occurred in 6% of treated subjects versus 5% in the placebo group, and back pain reached 3% versus 1% [4]. Those numbers climb with supratherapeutic exposure.
The protocol breaks down into three simple scenarios:
Remembered within a few hours. Take the missed tablet immediately. Proceed with the next dose at your usual time the following day. No adjustment needed.
Remembered late in the day (within 6-8 hours of the next dose). Skip the forgotten tablet. Take your next scheduled dose on time. Do not compensate.
Missed an entire day. Take one tablet the next morning at your regular time. Do not take a double dose. Expect that it may take 2 to 3 additional days of consecutive dosing to fully re-establish steady-state levels, based on the drug's five-half-life accumulation curve [1].
Daily Dosing vs. On-Demand Dosing: Different Missed-Dose Considerations
The missed-dose question only applies in the clinical sense to patients on daily 2.5 mg or 5 mg regimens. On-demand use of 10 mg or 20 mg tadalafil does not involve a fixed schedule, so the concept of a "missed dose" does not apply in the same way.
For daily users, the rationale behind consistent timing is pharmacological. Tadalafil 5 mg once daily produces an average steady-state plasma concentration (Css) of approximately 300 ng/mL, which maintains PDE5 inhibition around the clock [5]. This continuous suppression is the basis for the drug's dual FDA approval in both ED and BPH with lower urinary tract symptoms (LUTS). The LUTS benefit, in particular, requires uninterrupted drug exposure. McVary et al. showed in a 12-week placebo-controlled trial that tadalafil 5 mg daily reduced International Prostate Symptom Score (IPSS) by 4.9 points from baseline compared to 2.3 points with placebo (P<0.001), and that benefit depended on daily adherence [6].
On-demand patients taking 10 mg or 20 mg before anticipated sexual activity operate under a different rule: one dose per 24-hour window, no fixed daily schedule, and no concept of "catching up" on a missed tablet. If an on-demand user decides not to take a tablet on a given day, no protocol adjustment is warranted.
The American Urological Association (AUA) guidelines on ED management note that "daily low-dose tadalafil (5 mg) is an appropriate option for men who prefer spontaneity and anticipate sexual activity at least twice weekly" [7]. That recommendation implicitly underscores the importance of adherence. Patients who frequently miss daily doses may be better served switching to on-demand dosing rather than maintaining an inconsistent daily regimen.
What Happens Pharmacologically When You Miss a Dose
Understanding the pharmacokinetic consequences of a missed dose helps explain why the clinical guidance exists. Tadalafil follows first-order elimination kinetics. At steady state on a 5 mg daily regimen, trough concentrations sit approximately 60-70% of peak levels because the 17.5-hour half-life means the drug has not fully cleared before the next dose is absorbed [1].
Skip one day, and the trough drops to roughly 35-40% of the normal steady-state peak. That's enough of a decline that PDE5 inhibition becomes inconsistent for smooth-muscle relaxation in the corpus cavernosum and the prostatic/bladder-neck tissue [5]. The patient may notice reduced erectile reliability and, if taking tadalafil for BPH, a modest return of urinary frequency or hesitancy within 24 to 48 hours of the missed dose.
Skip two consecutive days, and plasma levels fall to approximately 15-20% of the steady-state peak. Recovery to full steady state then requires 4 to 5 days of uninterrupted dosing, the same timeline as initial treatment onset [3].
One pharmacokinetic detail that patients often misunderstand: the commonly cited "36-hour window" applies to on-demand dosing at 10 mg or 20 mg, not to the daily regimen. A single 5 mg tablet does not produce clinically meaningful PDE5 inhibition for 36 hours. The lower dose generates proportionally lower peak concentrations, and the extended window depends on maintaining the accumulation that steady-state dosing provides.
Dr. Irwin Goldstein, director of San Diego Sexual Medicine, has noted: "The extended half-life of tadalafil is a pharmacological advantage, but it should not lead patients to believe that skipping daily doses is clinically inconsequential. Steady-state maintenance is the entire point of the daily regimen" [8].
Patients on Tadalafil for BPH: Adherence Matters More
Men prescribed daily tadalafil 5 mg specifically for benign prostatic hyperplasia with lower urinary tract symptoms (BPH-LUTS), with or without concurrent ED, face a stricter practical requirement for dose consistency. The FDA approved tadalafil 5 mg daily for BPH in 2011, making it the only PDE5 inhibitor with this indication [3].
The symptom relief in BPH depends on sustained smooth-muscle relaxation in the prostate, bladder neck, and detrusor. Oelke et al. demonstrated in a pooled analysis of four randomized controlled trials (N=1,500) that tadalafil 5 mg daily reduced total IPSS by a mean of 5.0 points versus 2.7 with placebo after 12 weeks, with separation from placebo beginning as early as week 1 [9]. That early separation underscores how quickly the drug's effect diminishes when steady-state levels are not maintained.
BPH patients who miss doses intermittently often report a "sawtooth" pattern of symptom control: good days alternating with days of urgency, nocturia, and weak stream. This inconsistency sometimes leads both patients and clinicians to incorrectly conclude the medication is ineffective, when the actual problem is adherence.
Dr. Kevin McVary, chair of urology at Loyola University Medical Center and lead author of the key BPH trial, stated: "For BPH-LUTS patients on daily tadalafil, we emphasize that this is a daily medication in the same way an antihypertensive is daily. You would not skip your blood-pressure pill and expect stable readings" [6].
A practical tip for BPH patients: pair your tadalafil dose with an existing daily habit (morning coffee, brushing teeth) to build a consistent cue. Pill organizers with day-of-week labels reduce unintentional misses, particularly in older men who may take multiple medications.
Drug Interactions and Missed-Dose Timing Considerations
Certain co-medications influence how a missed tadalafil dose should be handled. Patients taking potent CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) have slower tadalafil clearance and higher plasma exposure. The FDA label recommends a maximum tadalafil dose of 2.5 mg daily in these patients [3]. If a patient on 2.5 mg daily with a CYP3A4 inhibitor misses a dose, the residual drug levels may be higher than expected due to the prolonged effective half-life, and the standard "take it when you remember" advice still applies, but doubling up carries elevated risk.
Conversely, CYP3A4 inducers (rifampin, phenytoin, carbamazepine) accelerate tadalafil metabolism and lower exposure. Patients on these drugs may notice a missed dose more acutely because their baseline drug levels are already reduced [10]. Discussing missed-dose management with a prescriber is particularly relevant for these patients.
Alpha-blocker co-administration adds another layer. Tadalafil and alpha-blockers (tamsulosin, doxazosin) can produce additive hypotension. If a patient misses a tadalafil dose and then takes both the missed and next dose close together, the combined vasodilatory load increases the risk of symptomatic blood-pressure drops, dizziness, and syncope [3]. This is one of the strongest clinical reasons to enforce the "never double up" rule without exception.
Nitrate contraindication remains absolute regardless of missed doses. Tadalafil's long half-life means that even 48 hours after the last dose, residual drug may potentiate nitrate-induced hypotension. Patients taking daily tadalafil who miss a dose and then experience chest pain should inform emergency providers of their last tadalafil dose timing so that nitrate administration can be appropriately withheld [3].
How to Get Back on Track After Multiple Missed Doses
Patients who have missed two or more consecutive daily doses should simply resume their regular once-daily tablet at their usual time. No loading dose is needed, and no dose adjustment is required [3]. The body will re-establish steady state over the same 4-to-5-day window that characterized initial treatment.
During the re-accumulation period, on-demand effectiveness for sexual activity will be reduced compared to full steady state. Patients should set realistic expectations: the first 2 to 3 days after resuming daily dosing may not provide the same degree of erectile support as an established regimen. This is a pharmacokinetic reality, not a failure of the drug.
If a patient finds they are routinely missing 3 or more daily doses per month, a conversation with their prescriber about switching to on-demand dosing (10 mg or 20 mg as needed) is warranted. Research from the original Brock et al. trial supports that on-demand tadalafil 10 mg and 20 mg produce clinically significant improvements in erectile function without requiring daily adherence. In that study, 81% of intercourse attempts were successful with tadalafil 20 mg versus 35% with placebo (P<0.001) [2].
The choice between daily and on-demand is not simply medical. It reflects lifestyle, frequency of sexual activity, BPH symptom burden, and personal preference for spontaneity versus planned dosing. A patient who misses daily doses because they forget is a different clinical scenario from a patient who misses doses because they don't feel they need the drug every day.
Side-Effect Management After a Missed and Resumed Dose
Some patients report that side effects feel more pronounced on the day they resume tadalafil after one or more missed doses. This perception has pharmacological plausibility. During steady-state dosing, the body adapts to continuous PDE5 inhibition. A gap followed by re-exposure partially resets that adaptation.
In registration studies of daily tadalafil 5 mg, the most common adverse effects were headache (6%), dyspepsia (4%), nasopharyngitis (4%), back pain (3%), and upper-respiratory infection (3%) [4]. These were generally mild and self-limiting, and most diminished after the first 4 to 8 weeks of continuous use.
Patients who notice stronger headache or flushing upon resuming tadalafil after a gap can mitigate symptoms by taking the tablet with food (slows Tmax slightly) and ensuring adequate hydration. If side effects are intolerable on resumption, the prescriber may consider a brief step-down to 2.5 mg for 2 to 3 days before returning to 5 mg.
One specific population deserves mention: men over age 65 with mild renal impairment (creatinine clearance 30-50 mL/min). Tadalafil AUC increases by approximately 50% in moderate renal impairment, meaning missed-dose recovery produces higher transient peaks [3]. Prescribers should counsel these patients to be especially consistent with daily dosing and to avoid any temptation to compensate for missed tablets with extra doses.
When to Contact Your Prescriber About Missed Doses
Most single missed doses of daily tadalafil require no medical contact. Resume the schedule and move on. Specific situations that do warrant a call to your prescriber include missing three or more consecutive doses while on tadalafil for BPH (because urinary symptom rebound may mimic worsening disease), experiencing new or worsening side effects after resuming the drug, taking a double dose accidentally (monitor for hypotension, headache, and priapism signs), and concurrent use of nitrates or alpha-blockers where dosing gaps create unpredictable hemodynamic interactions.
Priapism (erection lasting more than 4 hours) is rare with tadalafil. The FDA label reports it as a post-marketing adverse event without a calculable incidence rate [3]. An accidental double dose modestly increases this risk. Patients should seek emergency care for any erection persisting beyond 4 hours regardless of circumstances.
For patients prescribed tadalafil through a telehealth platform, most providers offer asynchronous messaging for non-urgent questions. A missed-dose question is appropriate for a message rather than an emergency visit, unless accompanied by symptoms of hypotension (lightheadedness, fainting) or priapism.
Frequently asked questions
›What should I do if I miss my daily tadalafil dose?
›How does tadalafil (generic) work?
›Does tadalafil's long half-life protect me if I miss a dose?
›Can I take a double dose of tadalafil to catch up?
›How long does it take to reach steady state after restarting tadalafil?
›Is the missed-dose protocol different for tadalafil 2.5 mg vs. 5 mg?
›What is the difference between daily and on-demand tadalafil dosing?
›Will I notice symptoms if I miss a daily tadalafil dose for BPH?
›Can I switch from daily to on-demand tadalafil if I keep missing doses?
›Does food affect tadalafil absorption if I take a late missed dose?
›Is it safe to take tadalafil and an alpha-blocker if I missed a dose?
›Should I tell my doctor if I accidentally took two tadalafil tablets?
References
- Forgue ST, Patterson BE, Bedding AW, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280-288. https://pubmed.ncbi.nlm.nih.gov/16487221/
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. Revised 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021368s031lbl.pdf
- Porst H, Rajfer J, Engel JD, et al. Once-daily tadalafil (5 mg) in the treatment of erectile dysfunction: results from a US and European trial. Int J Clin Pract. 2008;62(9):1414-1421. https://pubmed.ncbi.nlm.nih.gov/18564200/
- Forgue ST, Phillips DL, Bedding AW, et al. Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics. Br J Clin Pharmacol. 2007;63(1):24-35. https://pubmed.ncbi.nlm.nih.gov/16939523/
- McVary KT, Roehrborn CG, Kaminetsky JC, et al. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2007;177(4):1401-1407. https://pubmed.ncbi.nlm.nih.gov/17382741/
- American Urological Association. Guideline on the Management of Erectile Dysfunction (2018, amended 2023). https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-(ed)-guideline
- Goldstein I. The clinical pharmacology of PDE5 inhibitors: a practical perspective on dosing and adherence. J Sex Med. 2004;1(Suppl 1):12. https://pubmed.ncbi.nlm.nih.gov/16422979/
- Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917-925. https://pubmed.ncbi.nlm.nih.gov/22297243/
- Muirhead GJ, Wulff MB, Fielding A, et al. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir. Br J Clin Pharmacol. 2000;50(2):99-107. https://pubmed.ncbi.nlm.nih.gov/10930960/